Severe Maternal and Neonatal Morbidity Among Gestational Carriers : A Cohort Study
- PMID: 39312777
- DOI: 10.7326/M24-0417
Severe Maternal and Neonatal Morbidity Among Gestational Carriers : A Cohort Study
Abstract
Background: Use of a gestational ("surrogate") carrier is increasingly common. Risk for maternal and neonatal adversity is largely unknown in this birthing population.
Objective: To determine the risk for severe maternal morbidity (SMM) and severe neonatal morbidity (SNM) in gestational carriers.
Design: Population-based cohort study.
Setting: All of Ontario, Canada.
Participants: All singleton births at more than 20 weeks' gestation, from 2012 to 2021.
Measurements: Exposure was type of conception, namely, gestational carriage (main exposure), unassisted conception (comparison group 1), and in vitro fertilization (IVF) (comparison group 2). Main composite outcomes were SMM and SNM. Modified Poisson regression models generated weighted relative risks (wRRs) using propensity score-based overlap weighting. Secondary outcomes included hypertensive disorders of pregnancy, cesarean delivery, preterm birth, and postpartum hemorrhage.
Results: Of all eligible singleton births, 846 124 (97.6%) were by unassisted conception, 16 087 (1.8%) by IVF, and 806 (0.1%) by gestational carriage. Respective risks for SMM were 2.3%, 4.3%, and 7.8%. The wRRs were 3.30 (95% CI, 2.59 to 4.20) comparing gestational carriage with unassisted conception and 1.86 (CI, 1.36 to 2.55) comparing gestational carriage with IVF. Respective risks for SNM were 5.9%, 8.9%, and 6.6%, generating wRRs of 1.20 (CI, 0.92 to 1.55) for gestational carriage versus unassisted conception and 0.81 (CI, 0.61 to 1.08) for gestational carriage versus IVF. Hypertensive disorders, postpartum hemorrhage, and preterm birth at less than 37 weeks were also significantly higher contrasting gestational carriers to either comparison group.
Limitation: Absence of information about indications for choosing a gestational carrier, and oocyte or sperm donor source.
Conclusion: Among singleton births of more than 20 weeks' gestation, a higher risk for SMM and adverse pregnancy outcomes was seen among gestational carriers compared with women who conceived with and without assistance. Although gestational carriage was associated with preterm birth, there was less clear evidence of severe neonatal morbidity. Potential mechanisms for higher maternal morbidity among gestational carriers require elucidation, alongside developing special care plans for gestational carriers.
Primary funding source: The Canadian Institutes of Health Research.
Conflict of interest statement
Similar articles
-
Severe maternal morbidity in women with high BMI in IVF and unassisted singleton pregnancies.Hum Reprod. 2018 Aug 1;33(8):1548-1556. doi: 10.1093/humrep/dey224. Hum Reprod. 2018. PMID: 29982477
-
Attention-deficit hyperactivity disorder in children born to mothers with infertility: a population-based cohort study.Hum Reprod. 2022 Aug 25;37(9):2126-2134. doi: 10.1093/humrep/deac129. Hum Reprod. 2022. PMID: 35670758 Free PMC article.
-
Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method.J Minim Invasive Gynecol. 2021 Jul;28(7):1357-1366.e2. doi: 10.1016/j.jmig.2020.10.004. Epub 2020 Oct 14. J Minim Invasive Gynecol. 2021. PMID: 33065259
-
Risk of spontaneous preterm birth in singleton pregnancies conceived after IVF/ICSI treatment: meta-analysis of cohort studies.Ultrasound Obstet Gynecol. 2018 Jan;51(1):43-53. doi: 10.1002/uog.18930. Ultrasound Obstet Gynecol. 2018. PMID: 29114987 Review.
-
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 May 23;5:CD009613. doi: 10.1002/14651858.CD009613.pub4 PMID: 28602020 Free PMC article. Updated. Review.
MeSH terms
LinkOut - more resources
Full Text Sources